LivaNova PLC
LIVN62
$51.23arrow_drop_up0.94%$0.48
LIVN62
$51.23
arrow_drop_up0.94%Performance History
| Key Stats | |
|---|---|
| Open | $50.80 |
| Prev. Close | $50.75 |
| EPS | -0.31 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 50.64 | 51.40 |
| 52 Week Range | 42.75 | 64.47 |
| Ratios | |
|---|---|
| EPS | -0.31 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About LivaNova PLC (LIVN)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. William A. Kozy
- Headquarters
- London
- Employees
- 2900
- Exchange
- NASDAQ
Keep an eye on LivaNova PLC
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is LivaNova PLC's (LIVN) price per share?
The current price per share for LivaNova PLC (LIVN) is $51.23. The stock has seen a price change of $0.48 recently, indicating a 0.95% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for LivaNova PLC (LIVN)?
For LivaNova PLC (LIVN), the 52-week high is $64.48, which is 25.85% from the current price. The 52-week low is $42.75, the current price is 19.84% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is LivaNova PLC (LIVN) a growth stock?
LivaNova PLC (LIVN) has shown an average price growth of 0.41% over the past three years. It has received a score of 40 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LivaNova PLC as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is LivaNova PLC (LIVN) stock price performance year to date (YTD)?
As of the latest data, LivaNova PLC (LIVN) has a year-to-date price change of 1.37%. Over the past month, the stock has experienced a price change of 11.27%. Over the last three months, the change has been -5.91%. Over the past six months, the figure is -8.49%. Looking at a longer horizon, the five-year price change stands at -34.02%.
help
Is LivaNova PLC (LIVN) a profitable company?
LivaNova PLC (LIVN) has a net income of $17.55M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 68.09% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 13.27% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.15B, with a revenue growth rate of 12.89%, providing insight into the company's sales performance and growth. The gross profit is $785.45M. Operating income is noted at $98.95M. Furthermore, the EBITDA is $144.73M.
help
What is the market capitalization of LivaNova PLC (LIVN)?
LivaNova PLC (LIVN) has a market capitalization of $2.76B. The average daily trading volume is 487.01K, indicating the stock's liquidity and investor engagement.
News
ELECTROTHERAPY
TENS
CHRONIC PAIN
MARKET GROWTH
TECHNOLOGY ADVANCEMENTS
9/17/2024Global Electrotherapy System Research Report 2024: A $1.65 Billion Market by 2030 - TENS Segment Dominates as Demand for Chronic Pain Management Grows
CARDIOVASCULAR SURGERY DEVICES
BEATING HEART SURGERY SYSTEMS
PERFUSION DISPOSABLES
UNITED STATES MARKET
9/16/2024United States Cardiovascular Surgery Devices Market Outlook to 2033: Focus on Beating Heart Surgery Systems and Perfusion Disposables
CMR SURGICAL
DANIEL MOORE
MEDICAL TECHNOLOGY
SURGICAL ROBOTICS
7/15/2024CMR Surgical appoints Daniel Moore as Non-Executive Chairman - GlobeNewswire
5/1/2024
LivaNova (LIVN) Q1 Earnings and Revenues Top Estimates
4/25/2024
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
4/24/2024
LivaNova (LIVN) Earnings Expected to Grow: Should You Buy?